Market Cap: $10.13B
Market Cap: $10.13B
Open
$136.08
Prev. Close
$87.67
High
$137.33
Low
$133.88
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts.
Albemarle Corporation trades on the New York Stock Exchange under the ticker ALB, priced in USD.
Albemarle Corporation has a market capitalisation of $10.13B, based on its latest share price.
ALB trades at 202.00 times its trailing 12-month earnings.
Over the past 52 weeks ALB has traded between $85.22 and $221.00.
Yes. Albemarle Corporation's dividend yields 1.68% at the current share price, paying out 159% of its earnings.
Profitable, with a net margin of 3.8% over the last 12 months.
The analyst consensus rating for ALB is Buy. Analysts' average 12-month price target of $182.27 implies 112% upside.
Jerry Kent Jr. is the CEO of Albemarle Corporation, which is headquartered in Charlotte.
Generated automatically from reported financial data. General information only, not financial advice.

Albemarle Corporation's Resilient Performance Amidst Market Dynamics Albemarle Corporation ( ALB ) continues to exhibit a robust financial trajectory in the specialty chemicals sector, particularly dr…
Albemarle Corporation (Ticker: ALB) continues to demonstrate its position as a key player in the specialty chemicals industry, particularly with its latest financial results highlighting impressive gr…
Albemarle Corporation Enhances Liquidity Through Cash Tender Offers Albemarle Corporation, a leading global provider of critical materials for mobility, energy, connectivity, and health, is proactivel…
REalloys Inc.: Pioneering Solutions in the Rare Earth Supply Chain In an era characterized by the demand for advanced materials in defense and high-performance manufacturing, REalloys Inc. emerges as…